407P Pembrolizumab Expanded Access Program (EAP) in Taiwan for patients with progressive advanced melanoma after prior ipilimumab treatment
2016 ◽
Vol 34
(15_suppl)
◽
pp. e21058-e21058
2013 ◽
Vol 36
(3)
◽
pp. 215-222
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 19
(6)
◽
pp. 761-768
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. 9525-9525
◽
Keyword(s):
2017 ◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. e19027-e19027